ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pakistan seeks China's help for insurance cover of 6 CPEC projects

Islamabad [Pakistan], November 10 (ANI): Pakistan has sought the Chinese government's intervention to persuade China Export and Credit Insurance Corporation, Sinosure, to clear about USD 13 billion insurance cover of energy and infrastructure projects on a priority basis, a media report said.

ANI Nov 10, 2021 14:39 IST googleads

Representative image

Islamabad [Pakistan], November 10 (ANI): Pakistan has sought the Chinese government's intervention to persuade China Export and Credit Insurance Corporation, Sinosure, to clear about USD 13 billion insurance cover of energy and infrastructure projects on a priority basis, a media report said.
The Chinese State insurer, Sinosure has to underwrite all foreign investments and debts but has been holding back insurance cover of about USD 5 billion to six major power projects of over 3,500MW under the China-Pakistan Economic Corridor (CPEC). It also has to underwrite USD 8-9 bn insurance cover to Mainline-1, a 1,733km railway line from Karachi to Peshawar, reported Dawn.
Khalid Mansoor, Special Assistant to Pakistan Prime Minister on CPEC, on Tuesday said that he had taken up the matter with China's Ambassador in Islamabad.
All issues are related to strategically important projects, including ML-1 and six energy projects including Gwadar, Karrot, Kohala and Azad Pattan, Thar Block-VI and Thal-Nova power projects besides Quaid-i-Azam Solar power project.
"We have written two separate letters to China's National Development and Reform Commission for resolution of issues hampering the financial close of six energy projects and the term sheet for ML-I project," said Mansoor.
The nature of the friendly relationship between Pakistan and China was such that their companies had never called government guarantees despite huge overdue receivables from Pakistan, he added.
Mansoor said that the Chinese lenders were ready to provide funds for projects but Sinosure had to give the insurance policy. Many of these projects have already advanced with equity investment and could not be delayed for the debt part, according to Dawn. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Asia

China’s expanding system of censorship exposed in Dharamshala

China’s expanding system of censorship exposed in Dharamshala

The event titled "Understanding China's System of Political Repression: Voices of Resistance through Art and Journalism" brought together prominent voices critical of China's information control, as reported by Phayul.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.